|
PMO Patients (100% Female), age 69 years, T-Score = −3.0
| |
|
historical vertebral + incident vertebral fracture
| |
|
Teriparatide vs. No Treatment
|
132
|
|
Teriparatide vs. bisphosphonate
|
102
|
|
incident vertebral fracture
| |
|
Teriparatide vs. No Treatment
|
102
|
|
Teriparatide vs. bisphosphonate
|
77
|
|
GIOP Patients (80% Female), age 69 years, T-Score = −2.5
| |
|
historical vertebral + incident vertebral fracture
| |
|
Teriparatide vs. No Treatment
|
153
|
|
Teriparatide vs. bisphosphonate
|
117
|
|
incident vertebral fracture
| |
|
Teriparatide vs. No Treatment
|
140
|
|
Teriparatide vs. bisphosphonate
|
106
|
